METHOD FOR TREATING OBESITY WITH ANTI-OBESITY FORMULATIONS AND OMEGA 3 FATTY ACIDS FOR THE REDUCTION OF BODY WEIGHT IN CARDIOVASCULAR DISEASE PATIENTS (CVD) AND DIABETICS
Jason YANTHA;Valerie SCHINI-KERTH;Rachelle MACSWEENEY;George JACKOWSKI;Nisar SHAIKH
发明人:
George JACKOWSKI,Rachelle MACSWEENEY,Nisar SHAIKH,Jason YANTHA,Valerie SCHINI-KERTH
申请号：
US14231568
公开号：
US20150272920A1
申请日:
2014.03.31
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Combinations of one or more anti-obesity drugs with mixtures of an omega-3 fatty acid formulation containing about 90% or more omega 3 fatty acids by weight comprised of a combination of Eicosapentaenoic acid (EPA), Docosapentaenoic acid (DPA) and Docosahexaenoic acid (DHA) in a weight ratio of EPA:DHA of from 5.7 to 6.3, wherein the sum of the EPA, DHA and DPA comprise about 82% by weight of the total formulation and about 92% of the total omega 3 fatty acid content of the composition are taught. EPA+DHA are about 80% of the total formulation and about 89% of the total omega 3 fatty acid content of the composition. The formulation may further contain specific amounts of arachidonic acid (AA) and of omega-3 fatty acids having 18 carbon atoms, including one or more of stearidonic acid (SDA) and alpha-linolenic acid (ALA). The application further teaches methods of administering such combinations, and is directed towards unit dosages of such combinations for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics.
